Computer Science · Artificial Intelligence
A Unique Cell Surface Antigen Identifying Lymphoid
Malignancies Of B Cell Origin, Lee M. Nadler, Jerome Ritz, Russell Hardy, John M. Pesando, Stuart F. Schlossman
See on the mapAbstract
cific for a unique B cell surface differentiation antigen was used to characterize the malignant cells from pa-tients with leukemias or lymphomas. All tumor cells from patients with lymphomas or chronic lymphocytic leukemias, bearing either monoclonal K or X light chain, expressed the Bl antigen. In contrast, tumor cells from T cell leukemias and lymphomas or acute myeloblastic leukemias were unreactive. Approximately 50 % of acute lymphoblastic leukemias (ALL) of non-T origin and 50 % of chronic myelocytic leukemia in blast crisis were also anti-Bl reactive. Moreover, 21 of 28 patients with the common ALL antigen (CALLA) positive form ofALL were anti-B1 positive, whereas 0 of 13 patients with CALLA negative ALL were reactive. These observations demonstrate that an antigen present on normal B cells is expressed on the vast majority of B cell lymphomas and on-75 % of CALLA positive ALL, suggesting that these tuimors may share a common B cell lineage.